Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

LENZ

LENZ Therapeutics (LENZ)

LENZ Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LENZ
DateTimeSourceHeadlineSymbolCompany
08/27/20243:01PMGlobeNewswire Inc.LENZ Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:LENZLENZ Therapeutics Inc
08/14/20243:05PMGlobeNewswire Inc.LENZ Therapeutics Reports Second Quarter 2024 Financial ResultsNASDAQ:LENZLENZ Therapeutics Inc
08/12/20247:00AMGlobeNewswire Inc.LENZ Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for LNZ100 for the Treatment of PresbyopiaNASDAQ:LENZLENZ Therapeutics Inc
08/07/20243:01PMGlobeNewswire Inc.LENZ Therapeutics to Report Second Quarter 2024 Financial Results on August 14, 2024NASDAQ:LENZLENZ Therapeutics Inc
07/15/20247:00AMGlobeNewswire Inc.LENZ Therapeutics Announces $30 Million Investment from Ridgeback CapitalNASDAQ:LENZLENZ Therapeutics Inc
06/10/20247:00AMGlobeNewswire Inc.LENZ Therapeutics to Host Key Opinion Leader Event on June 18, 2024NASDAQ:LENZLENZ Therapeutics Inc
05/30/20247:00AMGlobeNewswire Inc.LENZ Therapeutics to Present at the Jefferies Global Healthcare ConferenceNASDAQ:LENZLENZ Therapeutics Inc
05/21/20247:31AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LENZLENZ Therapeutics Inc
05/09/20243:18PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:LENZLENZ Therapeutics Inc
05/08/20244:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LENZLENZ Therapeutics Inc
05/08/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:LENZLENZ Therapeutics Inc
05/08/20243:01PMGlobeNewswire Inc.LENZ Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:LENZLENZ Therapeutics Inc
05/01/20243:01PMGlobeNewswire Inc.LENZ Therapeutics to Report First Quarter Financial Results and Business Update on May 8, 2024NASDAQ:LENZLENZ Therapeutics Inc
04/03/20246:00AMBusiness WireLENZ Therapeutics Announces Positive Topline Data from Phase 3 CLARITY Presbyopia TrialsNASDAQ:LENZLENZ Therapeutics Inc
04/02/20243:01PMBusiness WireLENZ Therapeutics to Host Investor Call to Discuss Topline Results from the Phase 3 CLARITY Presbyopia TrialsNASDAQ:LENZLENZ Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LENZ